Dalton WS - Search Results

1

Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells.

Hazlehurst LA, Argilagos RF, Dalton WS. Hazlehurst LA, et al. Among authors: dalton ws. Br J Haematol. 2007 Jan;136(2):269-75. doi: 10.1111/j.1365-2141.2006.06435.x. Br J Haematol. 2007. PMID: 17233818 Free article.

2

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.

Meads MB, Hazlehurst LA, Dalton WS. Meads MB, et al. Among authors: dalton ws. Clin Cancer Res. 2008 May 1;14(9):2519-26. doi: 10.1158/1078-0432.CCR-07-2223. Clin Cancer Res. 2008. PMID: 18451212 Review.

3

Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.

Shain KH, Yarde DN, Meads MB, Huang M, Jove R, Hazlehurst LA, Dalton WS. Shain KH, et al. Among authors: dalton ws. Cancer Res. 2009 Feb 1;69(3):1009-15. doi: 10.1158/0008-5472.CAN-08-2419. Epub 2009 Jan 20. Cancer Res. 2009. PMID: 19155309 Free PMC article.

4

Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.

Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, Dalton WS. Hazlehurst LA, et al. Among authors: dalton ws. Cancer Res. 2006 Feb 15;66(4):2338-45. doi: 10.1158/0008-5472.CAN-05-3256. Cancer Res. 2006. PMID: 16489039

5

Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Damiano JS, et al. Among authors: dalton ws. Blood. 1999 Mar 1;93(5):1658-67. Blood. 1999. PMID: 10029595 Free PMC article.

6

Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).

Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Hazlehurst LA, et al. Among authors: dalton ws. Oncogene. 2000 Sep 7;19(38):4319-27. doi: 10.1038/sj.onc.1203782. Oncogene. 2000. PMID: 10980607

7

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation.

Damiano JS, Hazlehurst LA, Dalton WS. Damiano JS, et al. Among authors: dalton ws. Leukemia. 2001 Aug;15(8):1232-9. doi: 10.1038/sj.leu.2402179. Leukemia. 2001. PMID: 11480565

8

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells.

Hazlehurst LA, Valkov N, Wisner L, Storey JA, Boulware D, Sullivan DM, Dalton WS. Hazlehurst LA, et al. Among authors: dalton ws. Blood. 2001 Sep 15;98(6):1897-903. doi: 10.1182/blood.v98.6.1897. Blood. 2001. PMID: 11535527 Free article.

9

Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies.

Hazlehurst LA, Dalton WS. Hazlehurst LA, et al. Among authors: dalton ws. Cancer Metastasis Rev. 2001;20(1-2):43-50. doi: 10.1023/a:1013156407224. Cancer Metastasis Rev. 2001. PMID: 11831646 Review.

10

Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.

Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS, Tao J. Lwin T, et al. Among authors: dalton ws. Blood. 2007 Sep 1;110(5):1631-8. doi: 10.1182/blood-2006-11-060350. Epub 2007 May 14. Blood. 2007. PMID: 17502456 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page